Schnieders Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.17M | Buy |
9,070
+1,010
| +13% | +$118K | 0.15% | 91 |
|
|
2026
Q1 | $969K | Buy |
8,060
+434
| +6% | +$50.1K | 0.15% | 91 |
|
|
2025
Q4 | $803K | Buy |
7,626
+500
| +7% | +$46.9K | 0.13% | 95 |
|
|
2025
Q3 | $598K | Sell |
7,126
-1,767
| -20% | -$146K | 0.11% | 116 |
|
|
2025
Q2 | $704K | Sell |
8,893
-4,157
| -32% | -$330K | 0.12% | 106 |
|
|
2025
Q1 | $1.17M | Sell |
13,050
-3,028
| -19% | -$283K | 0.25% | 70 |
|
|
2024
Q4 | $1.6M | Sell |
16,078
-5,489
| -25% | -$566K | 0.32% | 53 |
|
|
2024
Q3 | $2.45M | Sell |
21,567
-4,034
| -16% | -$479K | 0.47% | 45 |
|
|
2024
Q2 | $3.17M | Sell |
25,601
-7,874
| -24% | -$1.01M | 0.64% | 36 |
|
|
2024
Q1 | $4.42M | Sell |
33,475
-216
| -0.6% | -$26.6K | 0.91% | 30 |
|
|
2023
Q4 | $3.67M | Sell |
33,691
-4,394
| -12% | -$456K | 0.81% | 31 |
|
|
2023
Q3 | $3.92M | Buy |
38,085
+174
| +0.5% | +$18.8K | 0.88% | 29 |
|
|
2023
Q2 | $4.37M | Buy |
37,911
+91
| +0.2% | +$10.3K | 0.91% | 27 |
|
|
2023
Q1 | $4.02M | Buy |
37,820
+51
| +0.1% | +$5.51K | 0.9% | 32 |
|
|
2022
Q4 | $4.19M | Buy |
37,769
+125
| +0.3% | +$12.8K | 0.96% | 31 |
|
|
2022
Q3 | $3.24M | Buy |
37,644
+7,550
| +25% | +$674K | 0.86% | 33 |
|
|
2022
Q2 | $2.74M | Buy |
30,094
+186
| +0.6% | +$16.5K | 0.82% | 36 |
|
|
2022
Q1 | $2.45M | Sell |
29,908
-902
| -3% | -$71.1K | 0.58% | 48 |
|
|
2021
Q4 | $2.36M | Sell |
30,810
-437
| -1% | -$34.8K | 0.55% | 49 |
|
|
2021
Q3 | $2.35M | Buy |
31,247
+4,392
| +16% | +$334K | 0.63% | 41 |
|
|
2021
Q2 | $2.09M | Sell |
26,855
-442
| -2% | -$32.9K | 0.57% | 44 |
|
|
2021
Q1 | $2.01M | Buy |
27,297
+4,992
| +22% | +$368K | 0.6% | 42 |
|
|
2020
Q4 | $1.74M | Buy |
22,305
+2,909
| +15% | +$222K | 0.57% | 47 |
|
|
2020
Q3 | $1.53M | Buy |
19,396
+7,762
| +67% | +$608K | 0.58% | 43 |
|
|
2020
Q2 | $858K | Buy |
11,634
+499
| +4% | +$37.6K | 0.34% | 61 |
|
|
2020
Q1 | $818K | Buy |
11,135
+362
| +3% | +$28.4K | 0.39% | 60 |
|
|
2019
Q4 | $935K | Buy |
10,773
+1,100
| +11% | +$90.3K | 0.34% | 75 |
|
|
2019
Q3 | $777K | Sell |
9,673
-1,441
| -13% | -$115K | 0.31% | 78 |
|
|
2019
Q2 | $889K | Buy |
11,114
+1,048
| +10% | +$80.2K | 0.35% | 76 |
|
|
2019
Q1 | $798K | Buy |
10,066
+32
| +0.3% | +$2.39K | 0.34% | 74 |
|
|
2018
Q4 | $731K | Hold |
10,034
| – | – | 0.36% | 72 |
|
|
2018
Q3 | $679K | Sell |
10,034
-1,121
| -10% | -$71.4K | 0.28% | 84 |
|
|
2018
Q2 | $646K | Sell |
11,155
-840
| -7% | -$47.4K | 0.27% | 86 |
|
|
2018
Q1 | $624K | Sell |
11,995
-5,421
| -31% | -$293K | 0.27% | 88 |
|
|
2017
Q4 | $935K | Sell |
17,416
-13,997
| -45% | -$776K | 0.39% | 71 |
|
|
2017
Q3 | $1.92M | Buy |
31,413
+131
| +0.4% | +$7.94K | 0.84% | 46 |
|
|
2017
Q2 | $1.91M | Buy |
31,282
+5,528
| +21% | +$337K | 0.89% | 38 |
|
|
2017
Q1 | $1.56M | Buy |
25,754
+1,572
| +7% | +$95.4K | 0.75% | 46 |
|
|
2016
Q4 | $1.36M | Buy |
24,182
+4,606
| +24% | +$270K | 0.7% | 48 |
|
|
2016
Q3 | $1.17M | Buy |
19,576
+5,633
| +40% | +$329K | 0.65% | 52 |
|
|
2016
Q2 | $766K | Hold |
13,943
| – | – | 0.43% | 75 |
|
|
2016
Q1 | $704K | Sell |
13,943
-2,358
| -14% | -$115K | 0.42% | 72 |
|
|
2015
Q4 | $822K | Sell |
16,301
-640
| -4% | -$32.3K | 0.51% | 63 |
|
|
2015
Q3 | $798K | Buy |
16,941
+576
| +4% | +$30.6K | 0.55% | 60 |
|
|
2015
Q2 | $889K | Sell |
16,365
-209
| -1% | -$11.7K | 0.52% | 59 |
|
|
2015
Q1 | $909K | Buy |
16,574
+1,231
| +8% | +$69.7K | 0.55% | 58 |
|
|
2014
Q4 | $831K | Buy |
15,343
+1,991
| +15% | +$111K | 0.55% | 59 |
|
|
2014
Q3 | $755K | Sell |
13,352
-1,048
| -7% | -$58.8K | 0.56% | 56 |
|
|
2014
Q2 | $795K | Buy |
14,400
+3,878
| +37% | +$212K | 0.56% | 52 |
|
|
2014
Q1 | $570K | Buy |
10,522
+629
| +6% | +$32.6K | 0.53% | 61 |
|
|
2013
Q4 | $472K | Buy |
+9,893
| New | +$452K | 0.46% | 68 |
|
Other funds holding MRK
ECSS
Schnieders Capital Management's MRK Position: Q2 2026 in Review
Schnieders Capital Management increased its Merck (MRK) stake by 13% in Q2 2026, buying an estimated $118K and bringing the position to 9,070 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #91.
Schnieders Capital Management first reported a position in MRK in Q4 2013 and has held it in 51 quarters since. The position peaked at $4.42M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Schnieders Capital Management held 9,070 shares of Merck worth $1.17M as of Q2 2026.
- Schnieders Capital Management bought 1,010 Merck shares in Q2 2026, an estimated $118K.
- Merck made up 0.15% of Schnieders Capital Management's portfolio in Q2 2026, its #91 holding.
- Schnieders Capital Management first reported a position in Merck in Q4 2013 and has held it in 51 quarters since.
- Schnieders Capital Management's Merck position peaked at $4.42M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Schnieders Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.